ExodusPoint Capital Management, LP

Position in PGEN — Precigen, Inc.

CIK 1736225 NEW YORK, NY

Position in PGEN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,778,001

+$445,386 QoQ

Shares Held

311,930

-9.4% QoQ

Ownership

0.087%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#51

of 210 holders

Holding Since

Jun 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ExodusPoint Capital Management, LP holds $280,525,216 across 101 Biotechnology names. PGEN ranks #44 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CYTK	Cytokinetics Inc	249,259	$21,234,374
2	BBIO	BridgeBio Pharma, Inc.	224,927	$16,752,562
3	ORKA	Oruka Therapeutics, Inc.	148,212	$14,105,336
4	VKTX	Viking Therapeutics, Inc.	361,126	$14,087,525
5	JAZZ	Jazz Pharmaceuticals plc	53,201	$12,819,844
6	NAMS	NewAmsterdam Pharma Co N.V.	304,334	$10,313,879
7	TGTX	Tg Therapeutics, Inc.	164,513	$9,038,344
8	DNLI	Denali Therapeutics Inc.	336,567	$8,656,503

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,778,001	311,930	-9.4%	Shares	Sole	2026-08-14
2026-03-31	$1,332,615	344,345	+1663.6%	Shares	Sole	2026-05-14
2022-06-30	$26,163	19,525	-4.1%	Shares	Sole	2022-08-22
2022-03-31	$42,976	20,368	-82.1%	Shares	Sole	2022-05-13
2021-12-31	$422,031	113,755	+57.5%	Shares	Sole	2022-02-11
2021-09-30	$360,317	72,208	+27.3%	Shares	Other	2021-11-15
2021-06-30	$369,847	56,725	+95.8%	Shares	Other	2021-08-16
2021-03-31	$199,630	28,974	+63.5%	Shares	Sole	2021-05-17
2020-12-31	$180,774	17,723	-58.9%	Shares	Other	2021-02-16
2020-09-30	$151,105	43,173	+242.6%	Shares	Sole	2020-11-16
2020-06-30	$62,874	12,600	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.